Live Nasdaq Composite: Markets Take Breather After Impressive Q2 Showing on Easing Oil Outlook
Q1 25 EPS
$-0.05
BEAT +30.56%
Est. $-0.07
Q1 25 Revenue
$926.9M
BEAT +4.35%
Est. $888.3M
vs S&P Since Q1 25
+5.5%
BEATING MARKET
ALHC +36.8% vs S&P +31.3%
Market Reaction
Did ALHC Beat Earnings? Q1 2025 Results
Alignment Healthcare opened 2025 with a standout quarter, posting a loss of $0.05 per share against a consensus estimate of $0.07, a 30.56% beat, while revenue of $926.93 million cleared Wall Street expectations by 4.35% and surged 47.5% year over ye… Read more Alignment Healthcare opened 2025 with a standout quarter, posting a loss of $0.05 per share against a consensus estimate of $0.07, a 30.56% beat, while revenue of $926.93 million cleared Wall Street expectations by 4.35% and surged 47.5% year over year. The primary engine behind those figures was a 31.7% jump in Medicare Advantage membership to roughly 217,500 enrollees, a scale-driven expansion that pushed total revenue well above guidance and helped swing adjusted EBITDA to a positive $20.18 million from a loss of $11.98 million a year ago, marking a meaningful inflection toward sustainable profitability. The company also announced a CFO transition, with healthcare finance veteran Jim Head assuming the role on May 2, as outgoing CFO Thomas Freeman moves to a strategic advisory position. Looking ahead, management raised the midpoint of its full-year 2025 outlook, now targeting revenue of $3.77 billion to $3.82 billion and adjusted EBITDA of $38 million to $60 million, signaling confidence that its technology-integrated care model can sustain the momentum through year-end.
Key Takeaways
- • Medicare Advantage membership growth of 31.7% year over year to approximately 217,500 members
- • Revenue growth of 47.5% year over year driven by membership expansion
- • Medical benefits ratio of 88.4% based on adjusted gross profit
- • Adjusted EBITDA swung to $20.2 million profit from $(12.0) million loss year over year
- • Strong first-quarter clinical performance and enrollment growth momentum
- • Integration of technology, clinical management, and member-first service
ALHC YoY Financials
Q1 2025 vs Q1 2024, source: SEC Filings
ALHC Revenue by Segment
With YoY comparisons, source: SEC Filings
“Alignment Healthcare's first-quarter performance reflects the strength of our model and the discipline of our execution, showing what's possible when technology, clinical management and member-first service operate as one. By staying focused on quality, clinical outcomes and member experience, we exceeded expectations across all key measures. With a strong start to the year and momentum building, we're confident in our ability to scale with purpose and deliver on our mission of Medicare Advantage done right.”
— John Kao, Q1 2025 Earnings Press Release
ALHC Earnings Trends
ALHC vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
ALHC EPS Trend
Earnings per share: estimate vs actual
ALHC Revenue Trend
Quarterly revenue: estimate vs actual
ALHC Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 MISS | $0.09 | $0.05 | -42.86% | $1.24B | +1.42% |
| Q4 25 BEAT FY | $-0.08 | $-0.05 | +37.50% | $1.01B | +0.94% |
| FY Full Year | $0.23 | $0.00 | -100.00% | $3.95B | +0.24% |
| Q3 25 BEAT | $-0.01 | $0.02 | +300.00% | $993.7M | +1.26% |
| Q2 25 BEAT | $-0.02 | $0.07 | +566.67% | $1.02B | +5.70% |
| Q1 25 BEAT | $-0.07 | $-0.05 | +30.56% | $926.9M | +4.35% |